Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    2.20 (3.13%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.33m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Subscription Rights Rump Placing

7 May 2026 08:55

RNS Number : 4097D
Geiger Counter Ltd
07 May 2026
 

Geiger Counter Limited (or the "Company")

7 May 2026

Exercise of outstanding Subscription Share Rights

 

The Company announces that further to the announcement on 6 May 2024, the Subscription Trustee has exercised all of the 6,815,308 outstanding Subscription Rights (the "Rump"). The ordinary shares of no par value in the capital of the Company ("Ordinary Shares") that arose from the exercise of the Rump have been sold by Cavendish Capital Markets Limited by way of a secondary market placing at a price of 70 pence per Ordinary Share, raising total gross proceeds for the Company of £2.5 million (based on the exercise price of 37.20 pence). The difference between the placing price and exercise price, after deduction of the costs (of exercising the Subscription Rights of the Rump and all the costs and expenses of the Subscription Trustee, the Registrar and the secondary market placing), being the resultant net proceeds, will be distributed by the Registrar to those shareholders who did not exercise their subscription rights, in proportion to their Shareholding on the Record Date, by 31 May 2026.

Accordingly, the Company announces that it will be issuing and allotting a further 6,815,308 Ordinary Shares, pertaining to the outstanding Subscription Rights exercised by the Subscription Trustee, subject to admission to trading. Application will be made for the new Ordinary Shares to be admitted to trading on the LSE. It is expected that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 11 May 2026.

Following the exercise of all Subscription Rights, the Company has raised a total of £7.8 million (on the exercise price of 37.20 pence). The funds raised will be invested in a manner consistent with the stated investment objectives of the Company.

 

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission the issued ordinary share capital of the Company will consist of 173,641,396 Ordinary Shares, of which 47,838,208 shares are held in treasury by the Company, resulting in 125,803,188 Ordinary Shares with voting rights attached. This figure of 125,803,188 Ordinary Shares may be used by the Company's shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the DTRs.

 

The information contained within this RNS is considered to be inside information prior to its release.

 

Enquiries

 

Manulife | CQS Investment Management 

Craig Cleland

T: +44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Tunga Chigovanyika

 (Corporate Finance)

T: +44 (0) 20 7397 1915

Daniel Balabanoff / Pauline Tribe (Sales)

T: +44 (0) 20 7220 0500

Summit Fund Services Jersey Limited

Christopher Foulds

T:+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ARIUBVBRNUUVRRR
Date   Source Headline
1st Jul 20257:31 amRNSEntry into Standstill Agreement
30th Jun 20255:22 pmRNSRelease of Interim Report and Financial Statements
30th Jun 20253:30 pmRNSNet Asset Value(s)
30th Jun 20259:02 amRNSTransaction in Own Shares
27th Jun 20254:09 pmRNSNet Asset Value(s)
26th Jun 20254:58 pmRNSNet Asset Value(s)
26th Jun 20259:53 amRNSShare Buyback
25th Jun 20251:24 pmRNSNet Asset Value(s)
24th Jun 202512:47 pmRNSNet Asset Value(s)
23rd Jun 20251:31 pmRNSNet Asset Value(s)
23rd Jun 20259:36 amRNSShare Buyback
20th Jun 20253:35 pmRNSMonthly Factsheet- May 2025
20th Jun 20251:10 pmRNSNet Asset Value(s)
19th Jun 202512:08 pmRNSNet Asset Value(s)
19th Jun 20259:48 amRNSHolding(s) in Company
18th Jun 20253:36 pmRNSNet Asset Value(s)
17th Jun 20251:13 pmRNSNet Asset Value(s)
16th Jun 20252:04 pmRNSNet Asset Value(s)
16th Jun 202512:35 pmRNSShare Buyback
13th Jun 20251:23 pmRNSNet Asset Value(s)
12th Jun 202512:59 pmRNSNet Asset Value(s)
11th Jun 202511:56 amRNSNet Asset Value(s)
11th Jun 202510:02 amRNSShare Buyback
10th Jun 20254:46 pmRNSNet Asset Value(s)
9th Jun 20253:27 pmRNSNet Asset Value(s)
9th Jun 20251:59 pmRNSTotal Voting Rights- May 2025
9th Jun 20259:38 amRNSShare Buyback
6th Jun 20251:45 pmRNSNet Asset Value(s)
6th Jun 202510:50 amRNSHolding(s) in Company
6th Jun 20258:05 amRNSShare Buyback
5th Jun 20251:08 pmRNSNet Asset Value(s)
5th Jun 202511:45 amRNSHolding(s) in Company
5th Jun 202511:30 amRNSHolding(s) in Company
4th Jun 20251:06 pmRNSNet Asset Value(s)
3rd Jun 20253:41 pmRNSNet Asset Value(s)
2nd Jun 20254:02 pmRNSNet Asset Value(s)
2nd Jun 20259:20 amRNSShare Buyback
30th May 20255:03 pmRNSNet Asset Value(s)
30th May 202510:47 amRNSShare Buyback
29th May 202512:42 pmRNSNet Asset Value(s)
28th May 20255:09 pmRNSHolding(s) in Company
28th May 20251:57 pmRNSNet Asset Value(s)
27th May 20253:17 pmRNSNet Asset Value(s)
23rd May 20253:35 pmRNSNet Asset Value(s)
22nd May 20254:22 pmRNSNet Asset Value(s)
22nd May 202510:55 amRNSMonthly Factsheet- April 2025
21st May 20253:25 pmRNSNet Asset Value(s)
21st May 20257:39 amRNSHolding(s) in Company
20th May 20253:41 pmRNSNet Asset Value(s)
19th May 20254:12 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.